Mati Therapeutics Inc.
Clinical Trials
15
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Safety and Intraocular Lowering Effect of Delivery of Travoprost Evolute® in Subjects With Elevated Intraocular Pressure
- Conditions
- Elevated Intraocular Pressure (IOP)
- First Posted Date
- 2021-07-14
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04962009
- Locations
- 🇺🇸
Stiles Eyecare Excellence, Overland Park, Kansas, United States
An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake
- Conditions
- Dry Eye Syndromes
- First Posted Date
- 2020-02-21
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT04280653
- Locations
- 🇺🇸
Cincinnati Eye Institute-Edgewood, Edgewood, Kentucky, United States
🇺🇸Ophthalmic Consultants of Long Island, Garden City, New York, United States
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
- Conditions
- InflammationPain
- First Posted Date
- 2018-04-12
- Last Posted Date
- 2021-10-12
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT03496467
- Locations
- 🇺🇸
Cincinnati Eye Institute-Edgewood, Edgewood, Kentucky, United States
🇺🇸Ophthalmic Consultants of Long Island, Garden City, New York, United States
🇺🇸Kerry Solomon, MD, Mount Pleasant, South Carolina, United States
A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma
- Conditions
- Ocular HypertensionOpen-Angle Glaucoma
- Interventions
- First Posted Date
- 2013-12-18
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 86
- Registration Number
- NCT02014142
- Locations
- 🇺🇸
Arizona Eye Center, Chandler, Arizona, United States
🇺🇸Arizona Glaucoma Specialists, Phoenix, Arizona, United States
🇺🇸Wolstan & Goldberg Eye Associates, Torrance, California, United States
A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
- Conditions
- GlaucomaOcular Hypertension (OH)
- First Posted Date
- 2011-11-29
- Last Posted Date
- 2013-09-26
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 57
- Registration Number
- NCT01481051
- Locations
- 🇺🇸
Sall Research Medical Center, Inc, Artesia, California, United States
🇺🇸Wolstan & Goldberg Eye Associates, Los Angeles, California, United States
🇺🇸West Coast Eye Care Associates, San Diego, California, United States
- Prev
- 1
- 2
- 3
- Next